HPV Clinical Trials
Find clinical trials for HPV. Search for HPV clinical trials in different cities and states across the United States.
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Sponsor:
TScan Therapeutics, Inc.
Location:
Code:
NCT05812027
Conditions
Head and Neck Cancer
Cervical Cancer
Non Small Cell Lung Cancer
Melanoma
Ovarian Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tumor and HLA Profiling
Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Location:
Code:
NCT04988074
Conditions
HPV-Related Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cemiplimab
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Sponsor:
Heath Skinner
Location:
Code:
NCT05388773
Conditions
Oropharynx Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
therapeutic conventional surgery
laboratory biomarker analysis
quality-of-life assessment
intensity-modulated radiation therapy
Cisplatin
Pembrolizumab Plus Olaparib in LA-HNSCC
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Location:
Code:
NCT05366166
Conditions
Squamous Cell Carcinoma of Head and Neck
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Olaparib
Cisplatin
IMRT (intensity modulated radiation therapy)
Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
Sponsor:
Lisette Nixon
Location:
Code:
NCT02215265
Conditions
Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cisplatin
Postoperative radiotherapy
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants with Advanced Solid Tumors
Sponsor:
Marengo Therapeutics, Inc.
Location:
Code:
NCT05592626
Conditions
Advanced Solid Tumors
Genital Neoplasm, Female
Urogenital Neoplasms
Lung Neoplasm
Neoplasms by Site
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
STAR0602
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Sponsor:
Christian Hinrichs
Location:
Code:
NCT05686226
Conditions
Cervical Cancer
Throat Cancer
Oropharynx Cancer
Anal Cancer
Vulva Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
E7 TCR-T cells
Aldesleukin
Shortened Course Adjuvant Radiotherapy Following TORS
Sponsor:
Abramson Cancer Center at Penn Medicine
Location:
Code:
NCT05714657
Conditions
HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Shortened Course Adjuvant Radiotherapy Following TORS
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Location:
Code:
NCT04178174
Conditions
Head and Neck Cancer
Oropharynx Cancer
Human Papilloma Virus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SABR boost and de-escalated chemoradiation
Standard chemoradiation